The National Basketball Association has concluded its investigation concerning a disagreement between Giannis Antetokounmpo and the Milwaukee Bucks over the superstar's injury status late in the 2025-26 season. The league has determined that no further action is required, according to sources familiar with the situation.
The probe was initiated after conflicting accounts emerged regarding Antetokounmpo's readiness to play. The player reportedly communicated to the NBA that he was healthy and eager to return to the court, while the team's medical staff had apparently not cleared him for action. This discrepancy fueled speculation about the MVP's future with the franchise.
The NBA's decision means the Milwaukee Bucks will not face penalties related to their handling of Antetokounmpo's health status. The investigation focused on whether the team's decision to shut down the player for the remainder of the regular season violated league policies.
Read More: NY Mets Injury Problems Cause Team to Lose Games
Details indicate that Antetokounmpo was slated for three-on-three scrimmages as part of a return-to-play protocol, but he reportedly declined to participate. This point appears to be a significant factor in the league's determination.
Background to the Dispute
The NBA launched its inquiry in April, shortly after Antetokounmpo himself voiced his ability to play. The two-time MVP did not feature in another regular-season game following these assertions.
The uncertainty surrounding Antetokounmpo's health and his relationship with the Bucks has been a subject of ongoing discussion. Doc Rivers stepped down as head coach the day after the team's final game of the season. Antetokounmpo, a nine-time All-NBA forward, is eligible to become a free agent after the upcoming season if he does not sign an extension. Reports from earlier in the season suggested Antetokounmpo had harbored doubts about the team's roster and had previously explored trade possibilities.
Read More: Joel Embiid Future Uncertain After 76ers Playoff Loss May 2026